KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Current Liabilities (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Total Current Liabilities readings, the most recent being $13.5 billion for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 21.29% to $13.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $13.5 billion, a 21.29% increase, with the full-year FY2025 number at $13.5 billion, up 5.16% from a year prior.
  • Total Current Liabilities hit $13.5 billion in Q1 2026 for Teva Pharmaceutical Industries, up from $13.5 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $13.8 billion in Q3 2024 to a low of $10.4 billion in Q1 2023.
  • Median Total Current Liabilities over the past 5 years was $11.8 billion (2023), compared with a mean of $12.1 billion.
  • Biggest five-year swings in Total Current Liabilities: surged 32.48% in 2024 and later fell 19.11% in 2025.
  • Teva Pharmaceutical Industries' Total Current Liabilities stood at $11.5 billion in 2022, then rose by 6.78% to $12.2 billion in 2023, then grew by 4.48% to $12.8 billion in 2024, then grew by 5.16% to $13.5 billion in 2025, then grew by 0.56% to $13.5 billion in 2026.
  • The last three reported values for Total Current Liabilities were $13.5 billion (Q1 2026), $13.5 billion (Q4 2025), and $11.5 billion (Q3 2025) per Business Quant data.